a to platí i pro u ívání Omega-3. Odkazy na zdroje 1. Mozaffarian, D., & Wu, J. H. (2012). (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? The Journal of Nutrition, 142(3), 614S-625S. 2. Bays, H. E. (2007). Safety considerations with omega-3 fatty acid therapy. The American Journal of Cardiology, 99(6A), 35C43C. 3.European Food Safety Authority. (2012). Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal, 8(3), 1461. 4. Koletzko, B., et al. (2007). Dietary fat intakes for pregnant and lactating women. British Journal of Nutrition, 98(5), 873-877. 5. Innis, S. M. (2007). Dietary (n-3) fatty acids and brain development. The Journal of Nutrition, 137(4), 855-859. 6. Kris-Etherton, P. M., et al. (2002). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 106(21), 2747-2757. 7. Harris, W. S., & Miller, M. (2018). Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacology & Therapeutics, 12(3), 3-17. 8. Goldberg, R. J., & Katz, J. (2007). A metaanalysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain, 129(1-2), 210-223. 9.Martins, J. G. (2009). EPA but not DHA appears to be responsible for the efficacy of omega-3 long-chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. Journal of the American College of Nutrition, 28(5), 525-542. 10.Yurko-Mauro, K., et al. (2010). Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's & Dementia, 6(6), 456-464. 11.Global Organization for EPA and DHA Omega-3s (GOED): goedomega3.com 12. Dyerberg, J., et al. (2010). Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes and Essential Fatty Acids, 83(3), 137-141. 13.Lawson, L. D., & Hughes, B. G. (1988). Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochemical and Biophysical Research Communications, 152(1), 328-335. 14.Hooper, L., et al. (2004). Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database of Systematic Reviews, (4). 15.Faruque, O., et al. (2019). A systematic review and meta-analysis of the effect of omega-3 fatty acids on bleeding risk in patients undergoing surgery. Clinical Nutrition, 38(4), 1829-1838. 16. Spronk, H. M., et al. (2003). Vitamin K status and bone mass in women with and without aortic atherosclerosis: a populationbased study. Calcified Tissue International, 73(1), 21-26. Kapitola: Jak správn u ívat Omega-3 dopl ky 800 182 572 7:30-16:30 (Pá: do14:00) Vyhlídka 39, 63800 Brno, eská republika Tel: +420 545 222 863 Fax: +420 545 222 011 www.vitaminy-mineraly.cz Strana 59 V I
RkJQdWJsaXNoZXIy Nzg5MDg=